These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Prolonged estrogen therapy in postmenopausal women. WALLACH S; HENNEMAN PH J Am Med Assoc; 1959 Nov; 171():1637-42. PubMed ID: 13842608 [No Abstract] [Full Text] [Related]
64. [The role of disorders of lipid metabolism in the appearance of complications in the course of essential arterial hypertension]. Brauner R; Panaitescu G; Demayo A Med Interna (Bucur); 1969 May; 21(5):619-23. PubMed ID: 5344556 [No Abstract] [Full Text] [Related]
66. Estrogentranquilizer therapy for the menopausal patient. SIEGEL S; TENDLER J; PRINTZ S; ROBINSON MS Clin Med (Northfield); 1961 Oct; 8():1955-7. PubMed ID: 15445874 [No Abstract] [Full Text] [Related]
67. [USE OF SEX HORMONES IN ATHEROSCLEROSIS]. MIASNIKOV LA Sov Med; 1963 Nov; 27():33-6. PubMed ID: 14137990 [No Abstract] [Full Text] [Related]
68. [Symposium "Lipids and lipoproteins in atherosclerosis"]. Przegl Lek; 1987; 44(6):469-524. PubMed ID: 3685429 [No Abstract] [Full Text] [Related]
69. [Problems of the pathogenesis of arteriosclerosis]. Gerasimova EN Ter Arkh; 1975; 47(7):15-24. PubMed ID: 178063 [No Abstract] [Full Text] [Related]
70. [Arteriosclerosis and atherosclerosis]. Puddu P Minerva Med; 1975 Oct; 66(66):3454-7. PubMed ID: 1178136 [No Abstract] [Full Text] [Related]
71. Lipid metabolism in gout. Barlow KA Proc R Soc Med; 1966 Apr; 59(4):325-8. PubMed ID: 5937682 [No Abstract] [Full Text] [Related]
72. [The atherogenic potential. Critical survey on the relation between lipids and atherogenesis]. Scandigli G; Spigai C G Gerontol; 1968 Apr; 16(4):347-61. PubMed ID: 4886484 [No Abstract] [Full Text] [Related]
73. [Certain new ways of study on the pathogenesis of arteriosclerosis]. Gandzha IM; Miagkaia IP Vrach Delo; 1975 Nov; (11):1-5. PubMed ID: 1199028 [No Abstract] [Full Text] [Related]
75. [Arteriosclerosis and lipid metabolism]. SCHETTLER G Acta Gastroenterol Belg; 1956; 19(8-9):582-98. PubMed ID: 13372167 [No Abstract] [Full Text] [Related]
76. [Lipid metabolism in arteriosclerosis]. MARTIN E Dtsch Med J; 1957 Jun; 8(6):283-8. PubMed ID: 13447634 [No Abstract] [Full Text] [Related]
77. [The role of persistent Epstein-Barr herpesvirus infection in the etiology of arteriosclerosis and its complications]. Krylov AA; Kupchinskiĭ RA Kardiologiia; 1991 Jul; 31(7):74-7. PubMed ID: 1664007 [No Abstract] [Full Text] [Related]
78. Role of magnesium and potassium in the pathogenesis of arteriosclerosis. Rayssiguier Y Magnesium; 1984; 3(4-6):226-38. PubMed ID: 6399344 [TBL] [Abstract][Full Text] [Related]
79. [The significance of ovarian and testicular steroids in lipid metabolism and atherogenesis]. Marek J Vnitr Lek; 1992 Sep; 38(9):913-20. PubMed ID: 1481391 [TBL] [Abstract][Full Text] [Related]
80. [Do calcium antagonists inhibit the development of arteriosclerosis?]. Liszewska-Pfejfer D; Skarzyńska M Kardiol Pol; 1992 Aug; 37(8):108-12. PubMed ID: 1434326 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]